CCAP Stock Recent News

CCAP offers a compelling 11% dividend yield and trades at a steep 22% discount to NAV, providing a strong margin of safety. The portfolio is anchored by 91% first-lien loans and 99% sponsor-backed positions, helping to ensure high credit quality and stability. Recent earnings show improving NII coverage and special dividends, supporting both income and total return potential for investors.

Investors need to pay close attention to Crescent Capital stock based on the movements in the options market lately.

Caring about dividends can increase our returns, but caring about NAV can save our portfolio. Return and NAV protection must go hand in hand, because there can be no sustainable return without protecting the value of the underlying assets. As far as I am concerned, the way to protect my portfolio is to favor only securities with a positive NAV over time.

Crescent Capital BDC, Inc.'s Q2 results showed improved net investment income per share, outperforming peers and maintaining strong base dividend coverage at 110%, above sector average. Despite a higher debt-to-equity ratio and limited equity upside, CCAP's fundamentals are in line with or better than the sector average. Yet, the stock trades at a massive discount to NAV (~21%), far steeper than the sector average, creating an attractive risk-reward profile.

Crescent Capital BDC, Inc. (NASDAQ:CCAP ) Q2 2025 Earnings Conference Call August 14, 2025 12:00 PM ET Company Participants Daniel McMahon - Senior VP & Head of Public Investor Relations Gerhard Pieter Lombard - Chief Financial Officer Henry Sahn Chung - President Jason A. Breaux - Chief Executive Officer Conference Call Participants Christopher Nolan - Ladenburg Thalmann Mickey Max Schleien - Ladenburg Thalmann & Co. Inc., Research Division Robert James Dodd - Raymond James & Associates, Inc., Research Division Operator Good morning, and welcome to Crescent Capital BDC, Inc. Second Quarter Ended June 30, 2025 Earnings Conference Call.

Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.46 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.59 per share a year ago.

LOS ANGELES, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.46 per share and net income of $0.41 per share for the quarter ended June 30, 2025. Second quarter net investment income includes the impact of one-time accelerated amortization of $0.02 per share related to deferred financing costs. Net asset value (NAV) per share was $19.55 at June 30, 2025.

I believe BDC investors face higher odds of unfavorable returns over the next 1-3 years due to macro and sector-specific headwinds. Key risks include a negatively sloped interest rate curve, tight spreads, thin dividend coverage, and historically low non-accruals likely to mean-revert. My strategy: short- to medium-term profit seekers should exit BDCs, while long-term income investors should upgrade to higher-quality names.

Crescent Capital BDC trades at a 26% discount to NAV, which I believe is exaggerated and presents a re-rating opportunity. Despite a rising non-accrual ratio and higher payout, the dividend appears safe in the near term, supported by strong floating-rate First Lien assets. The company's net investment income has declined, due to increased non-accruals, but steady interest rates should support income, unless credit quality worsens.

Since the announcement of tariffs in early April, the BDC market has become a less interesting place for capital deployment (as we can imply from higher discounts). Yet, as it is usually the case, higher discounts mean more opportunities for patient investors. In this article, I discuss two 10%+ yielding BDCs, which, even before the uncertainty level spiked higher, were bargains and now have become even more attractive buys.